Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Liječenje vaskulitisa (CROSBI ID 227466)

Prilog u časopisu | pregledni rad (stručni)

Novak Srđan Liječenje vaskulitisa // Reumatizam, 2 (2013), 47-54

Podaci o odgovornosti

Novak Srđan

hrvatski

Liječenje vaskulitisa

Treatment of vasculitis depends on etiology and type of vasculitis. Gluccocorticoids are drug of choice in treatment of systemic vasculitis. While in vasculitis of large vessels treatment with gluccocorticoids is often sufficient, in ANCA associated vasculitis almost always intial combination of gluccocorticoids and immunosupresive drugs (cyclofosfamide in severe forms ; azatioprin and metotrrexate in moderate disease) is needed. Maintance therapy of ANCA associated vasculitis is methotrexate or azatioprin. From biologic therapy, in gigantocellular vasculitis treatment with tocilizumb has a great expectation, while in ANCA associated vasculitis recently rituximab was approved by regulatory agencies, and it is nontinferior to cyclofosfamide in induction of remission and prefarable in relapsing disease.

liječenje; sistemski vaskulitis

nije evidentirano

engleski

Treatment of vasculitis

nije evidentirano

systemic vasculitis; treatment

nije evidentirano

Podaci o izdanju

2

2013.

47-54

objavljeno

0374-1338

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost